$PPCH - Investment Highlights Targeted therapy
Post# of 376
Posted On: 05/20/2014 10:45:51 PM
$PPCH - Investment Highlights
Targeted therapy for metastatic cancer: Global demand for effective, safe and easy to administer cancer treatments increasing rapidly.
Expansive market demand: Seeking worldwide regulatory approval in several indications, targeting tumor types where few treatment options exist .
Multiple mechanisms of action: Our lead product exerts multiple effects inhibiting tumor growth & blood supply, and stopping it spreading. R&D may identify opportunities for developing new compounds.
Encouraging patient data: 15 years of scientific research and clinical experience suggests our lead product may be an effective treatment against cancer and warrants further development.
Unique intellectual property: Propanc is building an IP portfolio around our scientific understanding of the effects of proenzymes in cancer, new formulations, new routes of administration and potential new targets
Targeted therapy for metastatic cancer: Global demand for effective, safe and easy to administer cancer treatments increasing rapidly.
Expansive market demand: Seeking worldwide regulatory approval in several indications, targeting tumor types where few treatment options exist .
Multiple mechanisms of action: Our lead product exerts multiple effects inhibiting tumor growth & blood supply, and stopping it spreading. R&D may identify opportunities for developing new compounds.
Encouraging patient data: 15 years of scientific research and clinical experience suggests our lead product may be an effective treatment against cancer and warrants further development.
Unique intellectual property: Propanc is building an IP portfolio around our scientific understanding of the effects of proenzymes in cancer, new formulations, new routes of administration and potential new targets
(0)
(0)Propanc Biopharma, Inc. (PPCB) Stock Research Links
Scroll down for more posts ▼